Xoloninvest logo

Xoloninvest

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Xoloninvest is engaged in investment in early-stage companies, listing, and unlisted mezzanine investment.

Investor Profile

Xoloninvest has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • South Korea (50%)
  • United States (50%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Machine Learning
  • Medical
  • Neuroscience
  • Software
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xoloninvest frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quad Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Kolon Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DB Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Solidus Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Securities
North America, New York, United States, Nyack
Co-Investments: 1
Prophet Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Seoil & M
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
CTK Investments
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Xoloninvest?

NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Rebus Biosystems

Santa Clara, California, United States

Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.

Biotechnology
Series BNov 19, 2020
Amount Raised: $20,000,000